 |
Code of Federal Regulations (Last Updated: November 8, 2024) |
 |
Title 21 - Food and Drugs |
|
|
Chapter I - Food and Drug Administration, Department of Health and Human Services |
|
|
SubChapter A - General |
|
|
Part 54 - Financial Disclosure by Clinical Investigators |
| § 54.1 - Purpose. |
| § 54.2 - Definitions. |
| § 54.3 - Scope. |
| § 54.4 - Certification and disclosure requirements. |
| § 54.5 - Agency evaluation of financial interests. |
| § 54.6 - Recordkeeping and record retention. |